In this DLBCL roundtable, experts share which novel agents or combinations they are most interested in. Ruemu Birhiray, MD, leads an expert roundtable on the current treatment pathway in DLBCL. The expert panel assesses the current and expected utility for clinicians of MRD in DLBCL management decisions.